Chemoinformaics analysis of (+)-BETA-PHELLANDRENE
| Molecular Weight | 136.238 | nRot | 1 |
| Heavy Atom Molecular Weight | 120.11 | nRig | 7 |
| Exact Molecular Weight | 136.125 | nRing | 1 |
| Solubility: LogS | -4.209 | nHRing | 0 |
| Solubility: LogP | 3.685 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 27.3687 |
| nHD | 0 | BPOL | 16.0513 |
| QED | 0.519 |
| Synth | 3.826 |
| Natural Product Likeliness | 3.438 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.002 |
| HIA | 0.003 |
| CACO-2 | -4.382 |
| MDCK | 0.0000285 |
| BBB | 0.969 |
| PPB | 0.895743 |
| VDSS | 2.149 |
| FU | 0.084733 |
| CYP1A2-inh | 0.409 |
| CYP1A2-sub | 0.38 |
| CYP2c19-inh | 0.142 |
| CYP2c19-sub | 0.866 |
| CYP2c9-inh | 0.211 |
| CYP2c9-sub | 0.347 |
| CYP2d6-inh | 0.012 |
| CYP2d6-sub | 0.653 |
| CYP3a4-inh | 0.166 |
| CYP3a4-sub | 0.567 |
| CL | 11.289 |
| T12 | 0.479 |
| hERG | 0.031 |
| Ames | 0.024 |
| ROA | 0.045 |
| SkinSen | 0.93 |
| Carcinogencity | 0.874 |
| EI | 0.906 |
| Respiratory | 0.911 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.938956 |